• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RESPIRONICS INC. DREAMSTATION CPAP PRO W/HUM/HT/CELL, AUS; VENTILATOR, NON-CONTINUOUS (RESPIRATOR)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RESPIRONICS INC. DREAMSTATION CPAP PRO W/HUM/HT/CELL, AUS; VENTILATOR, NON-CONTINUOUS (RESPIRATOR) Back to Search Results
Model Number AUX400T15C
Medical Device Problem Code Degraded (1153)
Health Effect - Clinical Code Respiratory Tract Infection (2420)
Date of Event 03/08/2021
Type of Reportable Event Serious Injury
Event or Problem Description
The manufacturer received information alleging a continuous positive airway pressure (cpap) device's sound abatement foam became degraded and caused a patient to develop a respiratory infection.The patient was prescribed amoxicillin in response to the reported event.The manufacturer's investigation is ongoing.A follow-up report will be submitted when the manufacturer's investigation is complete.
 
Additional Manufacturer Narrative
The manufacturer previously reported an allegation of an issue related to sound abatement foam.This action was reported to fda per 21 cfr part 806.The device will be corrected per res 88058.Corrected data: d4 unique identifier (udi) number: previously reported as (b)(4) ; updated to (b)(4).E1 initial reporter (contact/address country/phone number): previously reported as (b)(6) ; updated to (b)(6).E2 health professional?: previously reported as no ; updated to ye.S e3 occupation: previously reported as non-healthcare professional ; updated to other health care professional.
 
Additional Manufacturer Narrative
The manufacturer previously reported an allegation of an issue related to sound abatement foam.Additional information was received and section b5 should be reported as : the manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer previously received information alleging an issue related to a cpap device's sound abatement foam.The patient has alleged to develop a respiratory infection.The patient was prescribed amoxicillin in response to the reported event.The reported event of respiratory infection and its reported severity was reviewed by the manufacturer's clinical expert.This event is assessed as not related to the device in this case.Based on the information available, the manufacturer concludes no further action is necessary.The device has not yet returned to the manufacturer for evaluation.At this time no further investigation can be performed.If any additional information is received, a follow-up report will be filled.Section b1, b2 has changed related to the complaint changing from the reported adverse event to a product problem.Section h1 has changed to reflect a malfunction.Section h6 health effect-impact code, type of investigation, investigation findings and investigation conclusions have been updated.
 
Additional Manufacturer Narrative
The manufacturer previously submitted mdr 2518422-2021-02783-3 with incorrect sections b1, b2, h1, h6.Corrections to previous mdr are made in this report as follows.Section b1 was corrected to adverse event and product problem.(only product problem was checked in previous mdr).Section b2 was corrected to other serious or important medical events.(previously it was blank).Section h1 was changed from malfunction to serious injury.Section h6- health impact code was updated.
 
Additional Manufacturer Narrative
Section g1 was missed to capture in the follow-up 2, which was updated in this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DREAMSTATION CPAP PRO W/HUM/HT/CELL, AUS
Common Device Name
VENTILATOR, NON-CONTINUOUS (RESPIRATOR)
Manufacturer (Section D)
RESPIRONICS INC.
1001 murry ridge lane
murrysville PA 15668
Manufacturer (Section G)
RESPIRONICS INC.
1001 murry ridge lane
murrysville PA 15668
Manufacturer Contact
kimberly shelly
6501 living place
pittsburgh, PA 15206
2673970028
MDR Report Key12280575
Report Number2518422-2021-02783
Device Sequence Number11754891
Product Code BZD
UDI-Device Identifier00606959034792
UDI-Public00606959034792
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
K131982
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Consumer,User Facility
Initial Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date (Section B) 06/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Model NumberAUX400T15C
Device Catalogue NumberAUX400T15C
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Received by Manufacturer 08/04/2021
Supplement Date Received by Manufacturer08/16/2021
02/08/2023
06/07/2023
06/07/2023
Initial Report FDA Received Date08/05/2021
Supplement Report FDA Received Date09/14/2021
04/25/2023
06/07/2023
06/23/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured07/24/2020
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
RES 88058
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age63 YR
Patient SexMale
-
-